Significant Differences in Body Plethysmography Measurements Between Hospitals in Patients Referred for Bronchoscopic Lung Volume Reduction.


Journal

Lung
ISSN: 1432-1750
Titre abrégé: Lung
Pays: United States
ID NLM: 7701875

Informations de publication

Date de publication:
10 2019
Historique:
received: 21 05 2019
accepted: 19 08 2019
pubmed: 2 9 2019
medline: 1 5 2020
entrez: 2 9 2019
Statut: ppublish

Résumé

During the evaluation of potential bronchoscopic lung volume reduction (BLVR) candidates in our hospital, we frequently observe patients with a lower residual volume (RV) value compared to the value measured in their referring hospital, although both measured by body plethysmography. We explored to what degree RV and other pulmonary function measurements match between referring hospitals and our hospital. We retrospectively analyzed a total of 300 patients with severe emphysema [38% male, median age 62 years (range 38-81), median forced expiratory volume in 1 s 29% (range 14-65) of predicted, and a median of 40 packyears (range 2-125)]. We measured a median RV of 4.47 l (range 1.70-7.57), which was a median 310 ml lower than in the referring hospitals (range - 3.04 to + 1.94), P < 0.001). In conclusion, this retrospective analysis demonstrated differences in RV measurements between different hospitals in patients with severe emphysema. Overestimation of RV can lead to unnecessary referrals for BLVR and potential treatment failures. To avoid disappointment and unnecessary hospital visits, it is important that body plethysmography measurements are accurately performed by applying preferably the unlinked method in these patients.

Identifiants

pubmed: 31473796
doi: 10.1007/s00408-019-00265-w
pii: 10.1007/s00408-019-00265-w
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

573-576

Références

Respiration. 2016;91(4):273-80
pubmed: 26982496
Respiration. 2017;94(4):380-388
pubmed: 28817821
Lancet Respir Med. 2017 Feb;5(2):147-156
pubmed: 27693408
Eur Respir J. 2005 Sep;26(3):511-22
pubmed: 16135736
Respiration. 2019;97(6):548-557
pubmed: 30836374
Pediatr Pulmonol. 2012 Jun;47(6):588-96
pubmed: 22038839
Respiration. 2015;90(4):306-13
pubmed: 26352833
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1151-1164
pubmed: 29787288
N Engl J Med. 2015 Dec 10;373(24):2325-35
pubmed: 26650153
Chest. 1989 Jan;95(1):117-23
pubmed: 2909328
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Med Phys. 2012 Mar;39(3):1650-62
pubmed: 22380397
Int J Chron Obstruct Pulmon Dis. 2018 Apr 18;13:1269-1277
pubmed: 29713160
Eur Respir J. 2005 Sep;26(3):420-8
pubmed: 16135722
Eur Respir J. 2012 Nov;40(5):1137-41
pubmed: 22441742

Auteurs

Jorrit B A Welling (JBA)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. j.b.a.welling@umcg.nl.
Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. j.b.a.welling@umcg.nl.
Department of Pulmonary Diseases AA11, University Medical Center Groningen, P.O. Box 30001, 9700RB, Groningen, The Netherlands. j.b.a.welling@umcg.nl.

Jorine E Hartman (JE)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Nick H T Ten Hacken (NHT)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Sonja W S Augustijn (SWS)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Huib A M Kerstjens (HAM)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Dirk-Jan Slebos (DJ)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Karin Klooster (K)

Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH